These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 36730145)
1. In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation. Jun M; Pinto H; Le QT; Quon A; Hara W; Coty J; McMillan A; Lu R; Winters E; Lira R; Colevas AD PLoS One; 2023; 18(2):e0276651. PubMed ID: 36730145 [TBL] [Abstract][Full Text] [Related]
2. Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3. Kawahira M; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H Jpn J Clin Oncol; 2017 Aug; 47(8):705-712. PubMed ID: 28431119 [TBL] [Abstract][Full Text] [Related]
3. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials. Kong L; Zhang Y; Hu C; Guo Y; Lu JJ Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis. Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410 [TBL] [Abstract][Full Text] [Related]
5. Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma. Takamizawa S; Honma Y; Murakami N; Mori T; Oka H; Yamamoto S; Kashihara T; Ito K; Kubo Y; Ikeda A; Matsumoto F; Omura G; Kobayashi K; Itami J; Kato K; Yoshimoto S Invest New Drugs; 2021 Apr; 39(2):564-570. PubMed ID: 32940872 [TBL] [Abstract][Full Text] [Related]
6. Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma. Chen R; Lu Y; Zhang Y; He R; Tang F; Yuan W; Li Y; Zhang X Medicine (Baltimore); 2021 Oct; 100(42):e27475. PubMed ID: 34678878 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02). Frikha M; Auperin A; Tao Y; Elloumi F; Toumi N; Blanchard P; Lang P; Sun S; Racadot S; Thariat J; Alfonsi M; Tuchais C; Cornely A; Moussa A; Guigay J; Daoud J; Bourhis J; Ann Oncol; 2018 Mar; 29(3):731-736. PubMed ID: 29236943 [TBL] [Abstract][Full Text] [Related]
8. Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma. Ng WT; Choi CW; But B; Ngan RKC; Tung S; Cheng AC; Kwong DLW; Lu TX; Chan ATC; Yiu H; Lee S; Wong F; Yuen KT; Chappell RJ; Lee AWM Clin Cancer Res; 2022 Jun; 28(12):2679-2689. PubMed ID: 35381064 [TBL] [Abstract][Full Text] [Related]
9. Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma. Zhu J; Duan B; Shi H; Li Y; Ai P; Tian J; Chen N Oral Oncol; 2019 Oct; 97():37-43. PubMed ID: 31421469 [TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma. Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467 [TBL] [Abstract][Full Text] [Related]
11. International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. Casanova M; Özyar E; Patte C; Orbach D; Ferrari A; Veyrat-Follet C; Errihani H; Pan J; Zhang L; Shen L; Grzegorzewski KJ; Varan A Cancer Chemother Pharmacol; 2016 Feb; 77(2):289-98. PubMed ID: 26666649 [TBL] [Abstract][Full Text] [Related]
12. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma]. Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432 [TBL] [Abstract][Full Text] [Related]
13. Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma. Zheng SH; Liu SR; Wang HB; Wei YH; Li H; Wang GN; Huang ZL; Ding SR; Chen C; Tao YL; Li XH; Glorieux C; Huang P; Wu YF; Xia YF JAMA Netw Open; 2021 Dec; 4(12):e2138444. PubMed ID: 34902036 [TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. Lee NY; Harris J; Kim J; Garden A; Mechalakos J; Pfister DG; Chan ATC; Hu K; Colevas AD; Frank S; Shenouda G; Bar-Ad V; Waldron JN; Harari PM; Raben A; Torres-Saavedra P; Le QT JAMA Netw Open; 2023 Jun; 6(6):e2316094. PubMed ID: 37266942 [TBL] [Abstract][Full Text] [Related]
15. Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. Herman LC; Chen L; Garnett A; Feldman LE; Smith B; Weichselbaum RR; Spiotto MT Oral Oncol; 2014 Jan; 50(1):52-8. PubMed ID: 24055193 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma. Kong L; Zhang YW; Hu CS; Guo Y Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin. Zeng Z; Yan RN; Tu L; Wang YY; Chen PR; Luo F; Liu L Sci Rep; 2018 Oct; 8(1):15581. PubMed ID: 30348970 [TBL] [Abstract][Full Text] [Related]
18. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma. Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277 [TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial. Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411 [TBL] [Abstract][Full Text] [Related]
20. Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study. Shim HJ; Kim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Mi YT; Lee JK; Lim SC; Chung JW; Cho SH Medicine (Baltimore); 2020 Dec; 99(49):e23173. PubMed ID: 33285692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]